Go to the profile of EUSA Pharma

EUSA Pharma

 
  • United Kingdom

About EUSA Pharma

Founded in March 2015, EUSA Pharma is a profitable commercial-stage specialty pharmaceutical company with global reach from its headquarters in the UK and its commercial operations across Europe and the USA. EUSA Pharma has a portfolio of approved Oncology therapeutic and supportive care products including: FOTIVDA® (tivozanib) for the treatment of advanced RCC, QARZIBA® (dinutuximab beta) for the treatment of HR Neuroblastoma, Caphosol® and Caphosol® DISPERSIBLE, for the treatment and prevention of Oral Mucositis.

Therapeutic Areas

Oncology

Technologies

Antimicrobial Biologics Diagnostics Regenerative medicine Surgery

Company Type

Pharmaceutical

State of Ownership

Private

Sponsorship Group

Partner Networker

Topics

Editions participated in:

March 2018